Careers  |  Sign In  |  Register  |   Twitter

Study Shows Grafix ‘Overwhelmingly’ Effective for Diabetic Foot Ulcers

Reuters reports that a new study shows that Osiris Therapeutics’s Grafix wound-care product “proved ‘overwhelmingly’ effective in treating diabetic foot ulcers, paving the way for increased reimbursement from insurers that will boost sales of the therapy.” Grafix, which was launched in the United States in 2010, is “a therapy that delivers stem cells directly to the site of a wound, helping regenerate tissue, while protecting the area from inflammation, scarring and infection.” The new post-marketing trial showed that 62 percent of patients on Grafix “achieved complete wound closure, compared with a 21 percent success rate in patients who received conventional treatment.”

Read the article published by Reuters.